One-year postoperative morbidity associated with near-infrared-guided indocyanine green (ICG) or ICG in conjugation with human serum albumin (ICG:HSA) sentinel lymph node biopsy

Surgical Innovation

Volumn 21, Issue 3, 2014, Pages 240-243

  Murawa, Dawid ^a   Polom, Karol ^a   Murawa, Pawel ^a,b  

^a Wielkopolska Cancer Centre   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

breast cancer; complications; indocyanine green; melanoma; morbidity; sentinel lymph node biopsy

Indexed keywords

ANTIESTROGEN; HUMAN SERUM ALBUMIN; INDOCYANINE GREEN; RADIOACTIVE COLLOID; RADIOACTIVE MATERIAL; UNCLASSIFIED DRUG; SERUM ALBUMIN;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EVALUATION; DRUG CONJUGATION; FEMALE; FUNCTIONAL DISEASE; HISTOPATHOLOGY; HUMAN; IMAGE GUIDED BIOPSY; INDOCYANINE GREEN ANGIOGRAPHY; LIMB SWELLING; LONG TERM CARE; LYMPH NODE DISSECTION; LYMPHEDEMA; MASTECTOMY; MELANOMA; MORBIDITY; NEUROPATHY; PAIN; POSTOPERATIVE PERIOD; RANGE OF MOTION; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; TATTOO; TUMOR VOLUME; ADVERSE EFFECTS; BREAST TUMOR; DIAGNOSTIC USE; FOLLOW UP; NEAR INFRARED SPECTROSCOPY; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; SKIN;

BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDOCYANINE GREEN; POSTOPERATIVE COMPLICATIONS; SENTINEL LYMPH NODE BIOPSY; SERUM ALBUMIN; SKIN; SPECTROSCOPY, NEAR-INFRARED;

EID: 84901784905     PISSN: 15533506     EISSN: 15533514     Source Type: Journal    
DOI: 10.1177/1553350613503737     Document Type: Article

References (28)

1. Wang Z, Wu LC, Chen JQ. Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-Analysis. Breast Cancer Res Treat. 2011 ; 129: 675-689
2. Kretschmer L, Thoms KM, Peeters S, Haenssle H, Bertsch HP, Emmert S. Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphadenectomy versus complete regional lymph node dissection. Melanoma Res. 2008 ; 18: 16-21
3. Del Bianco P, Zavagno G, Burelli P, et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol. 2008 ; 34: 508-513
4. Ashikaga T, Krag DN, Land SR, et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010 ; 102: 111-118
5. Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007 ; 25: 3657-3663
6. Polom K, Murawa D, Rho YS, Nowaczyk P, Hünerbein M, Murawa P. Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review. Cancer. 2011 ; 117: 4812-4822
7. Sevick- Muraca EM. Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. Annu Rev Med. 2012 ; 63: 18.1-18.15
8. Schaafsma BE, Mieog JS, Hutteman M, et al. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol. 2011 ; 104: 323-332
9. Hirche C, Mohr Z, Kneif S, Murawa D, Hünerbein M. High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer. J Surg Oncol. 2012 ; 105: 162-166
10. Hirche C, Murawa D, Mohr Z, Kneif S, Hünerbein M. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat. 2010 ; 121: 373-378
11. Murawa D, Hirche C, Dresel S, Hünerbein M. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. Br J Surg. 2009 ; 96: 1289-1294
12. Hirche C, Engel H, Kolios L, et al. An experimental study to evaluate the Fluobeam 800 imaging system for fluorescence-guided lymphatic imaging and sentinel node biopsy. Surg Innov. :
13. Hojo T, Nagao T, Kikuyama M, Akashi S, Kinoshita T. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer. Breast. 2010 ; 19: 210-213
14. Tagaya N, Yamazaki R, Nakagawa A, et al. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg. 2008 ; 195: 850-853
15. Polom K, Murawa D, Nowaczyk P, Rho YS, Murawa P. Breast cancer sentinel lymph node mapping using near infrared guided indocyanine green and indocyanine green-human serum albumin in comparison with gamma emitting radioactive colloid tracer. Eur J Sug Oncol. 2012 ; 38: 137-142
16. Polom K, Murawa D, Rho YS, Spychala A, Murawa P. Skin melanoma sentinel node biopsy using real-time fluorescence navigation with indocyanine green and indocyanine green with human serum albumin. Br J Dermatol. 2012 ; 166: 682-683
17. Speich R, Saesseli B, Hoffmann U, Neftel KA, Reichen J. Anaphylactoid reactions after indocyanine-green administration. Ann Intern Med. 1988 ; 109: 345-346
18. Moskovitz AH, Bush WH, Horvath KD. Anaphylactoid reaction to intraoperative cholangiogram. Report of a case, review of literature, and guidelines for prevention. Surg Endosc. 2001 1227 ; 15 :
19. Ishizawa T, Bandai Y, Ijichi M, Kaneko J, Hasegawa K, Kokudo N. Fluorescent cholangiography illuminating the biliary tree during laparoscopic cholecystectomy. Br J Surg. 2010 ; 97: 1369-1377
20. Rodrigues EB, Meyer CH, Mennel S, Farah ME. Mechanisms of intravitreal toxicity of indocyanine green dye: implications for chromovitrectomy. Retina. 2007 ; 27: 958-970
21. Hillenkamp J, Dydykina S, Klettner A, et al. Safety testing of indocyanine green with different surgical light sources and the protective effect of optical filters. Retina. 2010 ; 30: 1685-1691
22. Giuliano AE. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet. 1997 ; 350: 958
23. Silberstein E, Koretz M, Rosenberg L, Bogdanov-Berezovsky A. Long-term blue discoloration after intradermal injection of blue dye for sentinel lymph node biopsy. Isr Med Assoc J. 2009 ; 11: 446-447
24. Leong SP, Donegan E, Heffernon W, Dean S, Katz JA. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol. 2000 ; 7: 361-366
25. Mozzillo N, Caracò C, Chiofalo MG, et al. Sentinel lymph node biopsy in patients with cutaneous melanoma: outcome after 3-year follow-up. Eur J Surg Oncol. 2004 ; 30: 440-443
26. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg. 1996 ; 223: 217-224
27. Ruhlen JL. Tissue necrosis. Cutaneous and subcutaneous damage following extravasation of methylene blue. J Kans Med Soc. 1982 ; 83 236: 260
28. Hutteman M, Mieog JSD, van der Vorst JR, et al. Randomized double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients. Breast Cancer Res Treat. 2011 ; 127: 163-170